• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性皮质类固醇可能对冠状病毒感染具有保护作用。

Inhaled corticosteroids may have a protective effect against coronavirus infection.

机构信息

Allergy Service, Hospital Universitario Río Hortega, Valladolid University, Valladolid, Spain;

Allergy Service, Hospital Universitario Río Hortega, Valladolid University, Valladolid, Spain.

出版信息

Allergol Immunopathol (Madr). 2021 Jan 2;49(1):113-117. doi: 10.15586/aei.v49i1.40. eCollection 2021.

DOI:10.15586/aei.v49i1.40
PMID:33528938
Abstract

BACKGROUND

Spain has been severely affected by the COVID-19 epidemic, with 195,944 persons infected and 20,453 deaths at the time of writing. Older people with respiratory or cardiac conditions are most at risk.

OBJECTIVE

The aim was to compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma, who are considered vulnerable to COVID-19.

METHODS

We studied 134 nursing home residents and 139 patients with uncontrolled asthma, groups vulnerable to COVID-19. Demographic characteristics, clinical manifestations, outcomes, key laboratory results, and radiological images were collected from medical records. COVID-19 infection was detected by polymerase chain reaction (PCR).

RESULTS

Thirteen (9.3%) patients with uncontrolled asthma, all receiving inhaled corticosteroids were infected by COVID-19. Eighty (60%) nursing home residents were infected; only 28, all of whom had received inhaled corticosteroids, had a good prognosis.

CONCLUSIONS

Early treatment with inhaled corticosteroids may be helpful in COVID-19 infection. Persons with an allergy might have some protective mechanisms against coronavirus.

摘要

背景

西班牙受到 COVID-19 疫情的严重影响,截至撰写时,已有 195944 人感染,20453 人死亡。有呼吸道或心脏疾病的老年人风险最高。

目的

本研究旨在比较养老院居民和未控制的哮喘患者的呼吸道症状,这些人被认为容易感染 COVID-19。

方法

我们研究了 134 名养老院居民和 139 名未控制的哮喘患者,这些人群易感染 COVID-19。从病历中收集了人口统计学特征、临床表现、结局、关键实验室结果和影像学图像。通过聚合酶链反应(PCR)检测 COVID-19 感染。

结果

13 名(9.3%)接受吸入皮质激素治疗的未控制哮喘患者感染了 COVID-19。80 名(60%)养老院居民感染了 COVID-19;只有 28 人预后良好,他们都接受了吸入皮质激素治疗。

结论

早期使用吸入皮质激素治疗可能有助于 COVID-19 感染。过敏的人可能对冠状病毒有一些保护机制。

相似文献

1
Inhaled corticosteroids may have a protective effect against coronavirus infection.吸入性皮质类固醇可能对冠状病毒感染具有保护作用。
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):113-117. doi: 10.15586/aei.v49i1.40. eCollection 2021.
2
Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study.吸入性皮质类固醇与哮喘患者肺炎风险:一项病例对照研究。
Chest. 2013 Dec;144(6):1788-1794. doi: 10.1378/chest.13-0871.
3
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?哮喘和 COPD 患者因吸入皮质类固醇而降低 COVID-19 住院风险?
Expert Rev Respir Med. 2021 Apr;15(4):561-568. doi: 10.1080/17476348.2021.1850275. Epub 2020 Dec 3.
4
Successful treatment of coronavirus disease 2019 in a patient with asthma.一名哮喘患者的新型冠状病毒肺炎成功治疗案例。
Allergy Asthma Proc. 2020 Jul 1;41(4):296-300. doi: 10.2500/aap.2020.41.200044.
5
Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19: a meta-analysis.预先使用吸入性皮质类固醇与 COVID-19 致死或重症风险:一项荟萃分析。
J Asthma. 2022 Apr;59(4):787-790. doi: 10.1080/02770903.2021.1878531. Epub 2021 Feb 8.
6
The use of inhaled and related respiratory medications in Christchurch rest homes.克赖斯特彻奇养老院吸入及相关呼吸药物的使用情况
N Z Med J. 2003 Dec 12;116(1187):U709.
7
Effect of high dose inhaled corticosteroids on cell mediated immunity in patients with asthma.高剂量吸入性糖皮质激素对哮喘患者细胞介导免疫的影响。
Allergol Immunopathol (Madr). 2012 Mar-Apr;40(2):100-3. doi: 10.1016/j.aller.2011.11.001. Epub 2012 Jan 10.
8
[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]
Rev Med Liege. 2020;75(S1):130-132.
9
Inadequate follow-up controller medications among patients with asthma who visit the emergency department.前往急诊科就诊的哮喘患者中后续控制药物不足。
Ann Emerg Med. 2005 Oct;46(4):316-22. doi: 10.1016/j.annemergmed.2004.12.024.
10
Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.吸入性皮质类固醇与成人起病哮喘的哮喘控制:12 年随访研究。
Respir Med. 2018 Apr;137:70-76. doi: 10.1016/j.rmed.2018.02.025. Epub 2018 Mar 2.

引用本文的文献

1
The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis.吸入性皮质类固醇与 SARS-COV-2 感染风险之间的关联:系统评价和荟萃分析。
J Infect Public Health. 2023 May;16(5):823-830. doi: 10.1016/j.jiph.2023.03.019. Epub 2023 Mar 21.
2
Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations.白三烯抑制剂与地塞米松联用在预防低氧饱和度的新冠肺炎患者死亡方面显示出前景。
J Clin Transl Sci. 2022 May 16;6(1):e74. doi: 10.1017/cts.2022.401. eCollection 2022.
3
Understanding and Managing Severe Asthma in the Context of COVID-19.
在2019冠状病毒病背景下理解和管理重度哮喘
Immunotargets Ther. 2021 Dec 11;10:419-430. doi: 10.2147/ITT.S342636. eCollection 2021.